Fig. 4From: Anti-fibrotic efficacy of nintedanib in pulmonary fibrosis via the inhibition of fibrocyte activityNintedanib inhibits the growth of fibroblasts in response to growth factors produced by fibrocytes. The proliferation of fibroblasts cultured in the cell culture supernatant of fibrocytes with various concentrations of a nintedanib, b BGJ398, c imatinib, and d SU5416 (0–1 μM) was measured by a 3H thymidine incorporation assay. The proliferation of fibroblasts cultured with recombinant growth factors (FGF2: 30 ng/ml, PDGF-AA: 100 ng/ml, PDGF-BB: 100 ng/ml, VEGF-A: 100 ng/ml) for 72 h. 3H–TdR was pulsed for the final 18 h, and the incorporation of 3H–TdR was measured. e Data were analyzed using the Kruskal-Wallis H test and are displayed as median and interquartile range (n = 8–11, independent experiments each). In all graphs: *P < 0.05 versus the value in the group treated with fibrocyte supernatants alone a-d or control e Back to article page